Aptevo Therapeutics Inc logo

Aptevo Therapeutics Inc

Our innovative ADAPTIR™ platform technology brings a unique approach to cancer immunotherapy and improves outcomes.

56 employees · est. 2016 · Seattle, United States

VS
Marengo Therapeutics logo

Marengo Therapeutics

A new frontier in the fight against cancer– the right activation of the right immune cells

41 employees · est. 2015 · Cambridge, United States

Marengo Therapeutics is the older company (2016 vs 2015); Aptevo Therapeutics Inc is the larger of the two.

Side-by-Side Comparison

Aptevo Therapeutics Inc Marengo Therapeutics
Founded
2016 2015 older
Headquarters
Seattle, United States Cambridge, United States
Employees
56 larger 41
Industry
Biopharma, Biotechnology Health Care
Funding Stage
Post Ipo Equity Series B
Total Funding
$56.95M $80.00M
Funding Rounds
5 2
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biotech, Cancer Immunotherapy, Oncology, Hematology, ADAPTIR™ Platform Technology, Seattle, Innovation, Entrepreneurial Culture, Science Innovation, Therapeutics, Cancer Research, Empowering Work Environment Biotech Company, Clinical Stage, Cancer Treatment, Immunotherapy, T Cell Activation, Immune System, Anti-tumor, Therapeutic Platform, Cancer Immunotherapy, Long-term Immunity, Cancer Research, Oncology, Immunology, Biomedical Innovation
Website
aptevotherapeutics.com marengotx.com
Aptevo Therapeutics Inc logo

About Aptevo Therapeutics Inc

Aptevo Therapeutics Inc is a biotech company with a focus on bringing novel oncology and hematology therapeutics to market. The company prides itself on its innovative ADAPTIR™ platform technology, which offers a unique approach to cancer immunotherapy and aims to improve outcomes for cancer patient...

Marengo Therapeutics logo

About Marengo Therapeutics

Marengo Therapeutics: Marengo Therapeutics, a clinical stage biotech company, is pioneering an entirely new way to activate the body’s own immune system to mount a rapid, effective, and durable response against cancer. Their unique therapeutic platform selectively boosts T cells, turbocharging poten...

We will tell you when either one moves

BounceWatch watches Aptevo Therapeutics Inc and Marengo Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Aptevo Therapeutics In... and Marengo Therapeutics — by email.

Frequently Asked Questions

Aptevo Therapeutics Inc — Our innovative ADAPTIR™ platform technology brings a unique approach to cancer immunotherapy and improves outcomes.. Marengo Therapeutics — A new frontier in the fight against cancer– the right activation of the right immune cells. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Aptevo Therapeutics Inc has raised $56.95M while Marengo Therapeutics has raised $80.00M.
Aptevo Therapeutics Inc and Marengo Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Aptevo Therapeutics Inc with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Aptevo Therapeutics Inc on 9 Jun 2026, and Marengo Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes